Nonalcoholic Fatty Liver Disease
Offered By: Dartmouth College via Independent
Course Description
Overview
Dartmouth Health Continuing Education for Professionals Home, Nonalcoholic Fatty Liver Disease, 4/21/2022 8:00:00 AM - 4/21/2025 9:00:00 AM,
Presenter
Mary Drinane, MD
Department of Gastroenterology & Hepalology
Dartmouth Hitchcock Health
Learning Outcome(s)
Learners will be able to apply current clinical research and principles of evidence-based medicine to determine clinical diagnoses by formulating and implementing acceptable treatment modalities for Nonalcoholic Fatty Liver Disease.
Disclosure
The activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported NO financial relationship(s)* with ineligible companies**.
* A “financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).
** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
Presenter
Mary Drinane, MD
Department of Gastroenterology & Hepalology
Dartmouth Hitchcock Health
Learning Outcome(s)
Learners will be able to apply current clinical research and principles of evidence-based medicine to determine clinical diagnoses by formulating and implementing acceptable treatment modalities for Nonalcoholic Fatty Liver Disease.
Disclosure
The activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported NO financial relationship(s)* with ineligible companies**.
* A “financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).
** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
Tags
Related Courses
An Evidence-Based Approach to the Diagnosis and Management of Migraines in Adults in the Primary Care and General Neurology SettingStanford University via edX To Prescribe or Not To Prescribe? Antibiotics and Outpatient Infections
Stanford University via edX Free of Pain #1 - release back originated pains by yourself
Udemy The Clinical Picture of Celiac Disease and How to Make the Diagnosis
Columbia University via Independent How Common is Celiac Disease Around the World? Role of Gluten Timing and Quantity, and Environmental Risk Factors
Columbia University via Independent